Provider review
DoctorAdam review
Sells both GLP-1 molecules as daily tablets, with no injection offered.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
From $129 oral semaglutide and $199 oral tirzepatide
Visit DoctorAdamNo figure states a billing period, so the products can be ranked against each other but not costed.
Price as published
DoctorAdam
From $129 oral semaglutide and $199 oral tirzepatide
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Two things distinguish this one. The GLP-1s are sold as daily oral tablets with no injectable option beside them, which matters if the needle rather than the cost is your obstacle, and which is uncommon enough to be the reason to look here in the first place. And every product carries an in-stock label, which on a compounded catalog is genuinely informative — supply gaps are frequent in this category and most sellers say nothing about them until after an order is placed. What is missing is the denominator. The figures are introduced by from and carry no period at all: not a month, not a supply length, not a course. So you can tell which product costs more than which, and you cannot tell what either one costs to take. No milligram appears against either GLP-1, which on a daily tablet is a bigger gap than usual, since a daily oral product and a weekly injection cannot be compared on a monthly figure alone.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a daily tablet rather than a weekly injection
- You want to know whether a product is actually in stock before ordering
- You want several categories of treatment from one provider
Look elsewhere if
- You want to know what a month costs. No period is attached to any figure
- You want the injectable route as an option
- You want a dose behind the number
What it actually costs
Price as published
From $129 oral semaglutide and $199 oral tirzepatide
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. An oral-only GLP-1 catalog, which is rare and matters when the needle rather than the cost is the obstacle. In-stock labels on every product are unusual and genuinely informative on a compounded catalog. No figure states a billing period, so the products can be compared with each other but not costed, and no dose is published — a larger gap on a daily tablet, where a monthly figure alone says very little.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Both GLP-1 molecules are offered as daily oral tablets, with no injection required.
- Every product carries an in-stock label, which is unusual and useful on a compounded catalog.
- Figures are visible on the product cards without an intake.
Pharmacy, labs and oversight
DoctorAdam does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What DoctorAdam publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Two things distinguish this one. The GLP-1s are sold as daily oral tablets with no injectable option beside them, which matters to a reader for whom the needle is the obstacle rather than the cost, and which is uncommon enough to be the reason to look. And every product carries an in-stock label, which on a compounded catalog is genuinely informative — supply gaps are frequent in this category and most sellers say nothing about them until an order is placed. What is missing is the denominator. The figures are introduced by from and carry no period at all: not a month, not a supply length, not a course. So a reader can tell which product costs more than which, and cannot tell what either one costs to take. No milligram appears against either GLP-1, which on an oral product is a larger gap than usual, since daily tablets and weekly injections are not comparable on a per-month figure alone.
The honest cons
No figure states a billing period — not a month, a supply or a course.
- Every price is a floor introduced by from.
- No milligram appears against either oral product.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
DoctorAdam is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way DoctorAdam does. Both are partners: we may earn a commission if you start care through these links.
Partner
Sprout Health
$149 sema · $199 tirz
Standard plan, self-directed low dose
FDA warning letter · Sprout Health · September 2025 · addressed to Sprout Health Partners LLC dba Sprout Health. Details in our review.
Partner
Bodybuilding Health+
$179/mo sema · $209/mo tirz
Standard plan, self-directed low dose
Where this sits
#335 of 548
Ordered with the companies that pay us first, and DoctorAdam is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Direct Meds
From $249/mo sublingual · $297/mo injection
FDA warning letter · Direct Meds · September 2025 · addressed to directmeds.com, Inc. dba DirectMeds. Details in our review.
- Vs median
- $74/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by CraftedRx · ChemistryRx
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Direct Meds review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.